Arcus Biosciences (RCUS) PT Raised to $39 at Truist Securities
Tweet Send to a Friend
(Updated - October 7, 2025 9:24 AM EDT)
Truist Securities analyst Asthika Goonewardene raised the price target on Arcus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Asthika Goonewardene raised the price target on Arcus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
